Moreover, patients in the NR group in comparison to IgG/IgA antibody responders showed higher frequencies of autoimmune manifestations, including cytopenias (p = 0.049) and bronchiectasis (p = 0.011) (Figure 2A), revealing a more complex clinical phenotype. Here, CD79A is linked to bronchiectasis.